Director of Radioligand Therapies, Global MSAT (Advanced Therapies)

Company: Disability Solutions
Location: Spring House
Posted on: November 3, 2024

Job Description:

Johnson & Johnson is recruiting a Director of Radioligand Therapies, Global MSAT (Advanced Therapies) to be located in Spring House, PA, Malvern, PA, Raritan, NJ, or potentially remotely within the US.\rAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/. \rJohnson and Johnson Innovative Medicines is recruiting for the Advanced Therapies Manufacturing Science and Technology (MSAT) organization! We are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. Are you interested in joining a team that is positively impacting patients' lives by growing and scaling our high-quality cell, gene therapy and targeted radioligand therapy products? Apply today for this exciting opportunity to be part of the team!\rWorking closely with Development and Supply Chain teams, this Director of Radioligand Therapy will help establish a manufacturing process for radiopharmaceutical programs that will focus on automation, high throughput, reliability, and lower costs.\rThis includes establishing working relationships with new CMOs, identifying new technologies to ensure high quality and robust supply, and building radio ligand expertise within ATSC. This individual will develop a new product introduction process for radioligand therapies and build out a MSAT team that will provide technical ownership for transfer and manufacture Johnson and Johnson's first radioligand as part of our Advanced Therapies supply chain. This role partners closely with R&D, Quality, and Regulatory to ensure processes meet the needs of today and tomorrow.\rEssential functions:

• \r
• Technical SME for radioligand process, build radioligand capabilities within the Advanced Therapies MSAT organization.
• Establish Advanced Therapies Supply Chain process for technical transfer of radioligand therapies into commercial production, including launch support and capacity expansions once operational.
• Accountable for the delivery of key project milestones for technology transfers end-to-end.
• Provide technical support and oversight for planning and execution of manufacturing site activities from transfer through scale-up.
• Proactive risk mitigation and issue escalation (i.e., perform gap assessments, FMEA, process equipment evaluation)
• Ensure key performance indicators, CAPEX estimates, FTE estimates, and dashboards are maintained
• Implement digital/data analytics capabilities throughout the manufacturing process and supply chain to maximize data transparency, enabling ease of reporting results/data analysis of manufacturing processes
• Build technology platforms/standard work to accelerate development timelines, and streamline the technical transfer process.\r\r

Keywords: Disability Solutions, Cherry Hill , Director of Radioligand Therapies, Global MSAT (Advanced Therapies), Executive , Spring House, New Jersey